Nalls Sherbakoff Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.01K Buy
141
+28
+25% +$221 ﹤0.01% 412
2025
Q3
$1.21K Hold
113
﹤0.01% 399
2025
Q2
$1.09K Hold
113
﹤0.01% 401
2025
Q1
$1.68K Buy
+113
New +$1.74K ﹤0.01% 385
2023
Q4
$1.64K Hold
114
﹤0.01% 360
2023
Q3
$1.98K Hold
114
﹤0.01% 349
2023
Q2
$2.21K Hold
114
﹤0.01% 351
2023
Q1
$2.63K Buy
+114
New +$3.06K ﹤0.01% 355

Other funds holding OGN

Nalls Sherbakoff Group's OGN Position: Q4 2025 in Review

Nalls Sherbakoff Group increased its Organon & Co (OGN) stake by 25% in Q4 2025, buying an estimated $221 and bringing the position to 141 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #412.

Nalls Sherbakoff Group first reported a position in OGN in Q1 2023 and has held it in 8 quarters since. The position peaked at $2.63K in Q1 2023. 632 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Nalls Sherbakoff Group held 141 shares of Organon & Co worth $1.01K as of Q4 2025.
  • Nalls Sherbakoff Group bought 28 Organon & Co shares in Q4 2025, an estimated $221.
  • Organon & Co made up ﹤0.01% of Nalls Sherbakoff Group's portfolio in Q4 2025, its #412 holding.
  • Nalls Sherbakoff Group first reported a position in Organon & Co in Q1 2023 and has held it in 8 quarters since.
  • Nalls Sherbakoff Group's Organon & Co position peaked at $2.63K in Q1 2023.
  • 632 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Nalls Sherbakoff Group's 13F filing for Q4 2025, filed 12 Mar 2026.